312.39
前日終値:
$323.01
開ける:
$322
24時間の取引高:
1.94M
Relative Volume:
1.43
時価総額:
$60.77B
収益:
$325.78B
当期純損益:
$1.64B
株価収益率:
37.57
EPS:
8.3139
ネットキャッシュフロー:
$3.61B
1週間 パフォーマンス:
-2.35%
1か月 パフォーマンス:
-4.44%
6か月 パフォーマンス:
-5.00%
1年 パフォーマンス:
+11.11%
Cencora Inc Stock (COR) Company Profile
Compare COR vs MCK, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
COR
Cencora Inc
|
312.39 | 62.84B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
MCK
Mckesson Corp
|
842.25 | 105.22B | 397.96B | 4.55B | 9.64B | 34.77 |
|
CAH
Cardinal Health Inc
|
204.92 | 49.69B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
78.84 | 9.08B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
1.98 | 1.69B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | アップグレード | Jefferies | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
A Look at Cencora Inc (COR) After 3.3% Decline -- GF Value $288. - GuruFocus
What you need to know ahead of Cencora's earnings release - MSN
Lobbying Update: $1,150,000 of CENCORA INC. lobbying was just disclosed - Quiver Quantitative
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora, Inc. (COR) Stock Analysis: Evaluating a 23% Potential Upside in the Healthcare Distribution Sector - DirectorsTalk Interviews
Cencora Inc. stock (US15135B1017): Why does its pharmaceutical distribution dominance matter more no - AD HOC NEWS
Assessing Whether Cencora (COR) Is Undervalued Given Mixed Returns And A Rich Earnings Multiple - simplywall.st
Cencora, Inc. (COR) signs binding agreement to expand retina network with EyeSouth acquisition - MSN
Cencora Inc stock (US03073E1055): Why Google Discover changes matter more now - AD HOC NEWS
Cencora Inc stock (US03073E1055): Why its pharmaceutical distribution leadership matters more now fo - AD HOC NEWS
Moran Wealth Management LLC Sells 5,004 Shares of Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Bought by Asset Management One Co. Ltd. - MarketBeat
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
KBC Group NV Sells 151,164 Shares of Cencora, Inc. $COR - MarketBeat
What You Need to Know Ahead of Cencora's Earnings Release - Barchart
Cencora, Inc. $COR Shares Sold by Lbp Am Sa - MarketBeat
Cencora, Inc. $COR Shares Acquired by Assetmark Inc. - MarketBeat
Cencora sets May 6 date for second-quarter earnings release - MSN
Deals tracker: CPIhealth expands Indiana footprint - Modern Healthcare
Cencora, Inc. $COR Stake Lessened by State of Alaska Department of Revenue - MarketBeat
Robeco Institutional Asset Management B.V. Decreases Holdings in Cencora, Inc. $COR - MarketBeat
Weekly Trades: Is Cencora Inc subject to activist investor interest2026 Historical Comparison & Risk Managed Investment Entry Signals - baoquankhu1.vn
Massachusetts Financial Services Co. MA Sells 89,591 Shares of Cencora, Inc. $COR - MarketBeat
American Institute for Advanced Investment Management LLP Has $6.41 Million Stock Position in Cencora, Inc. $COR - MarketBeat
Cencora Sets May 6 Date for Second-Quarter Earnings Release - MyChesCo
Sumitomo Mitsui Trust Group Inc. Sells 35,834 Shares of Cencora, Inc. $COR - MarketBeat
All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside (NYSE:COR) - Seeking Alpha
Mid-Cap Value Portfolio's Cencora Inc(COR) Holding History - GuruFocus
Patterns Watch: Can Cencora Inc outperform in the next rallyEarnings Risk Summary & Weekly Breakout Watchlists - baoquankhu1.vn
Cencora Tops Daily Turnover at $330 Million as Strategic Overhaul Meets Cautious Caution - Bitget
V Square Quantitative Management LLC Takes $1.20 Million Position in Cencora, Inc. $COR - MarketBeat
Assessing Cencora (COR) Valuation After Recent Share Price Weakness - simplywall.st
Is Cencora Inc stock a top performer YTD2026 Price Momentum & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Cencora to acquire EyeSouth retina business for $1.1 billion - MSN
Cencora, Inc. (NYSE:COR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Cencora Inc. stock rises Wednesday, still underperforms market - MarketWatch
Cencora (COR) Analyst Rating Update: Evercore ISI Group Lowers P - GuruFocus
Evercore ISI Adjusts Price Target on Cencora to $360 From $420, Maintains Outperform Rating - marketscreener.com
Is Cencora (COR) Pricing Reflect Its DCF Value After Recent Healthcare Supply Chain Scrutiny - simplywall.st
Daytona Street Capital LLC Takes Position in Cencora, Inc. $COR - MarketBeat
Here's Why You Should Hold Cencora Stock in Your Portfolio Now - MSN
Cencora CFO James Cleary to retire June 30, 2026 - MSN
Cencora to Acquire EyeSouth Retina Business for $1.1 Billion - MyChesCo
Cencora, Inc. (COR) Stock forecasts - uk.finance.yahoo.com
Cencora Expands Retina Network As CFO Retirement Opens New Chapter - simplywall.st
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):